Geneos Wealth Management’s Viatris VTRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$58.4K Buy
3,677
+13
+0.4% +$201 ﹤0.01% 1401
2026
Q1
$49.5K Sell
3,664
-32
-0.9% -$448 ﹤0.01% 1437
2025
Q4
$46K Sell
3,696
-279
-7% -$3.01K ﹤0.01% 1426
2025
Q3
$39.4K Sell
3,975
-2,635
-40% -$25.6K ﹤0.01% 1467
2025
Q2
$59K Sell
6,610
-1
-0% -$8 ﹤0.01% 1479
2025
Q1
$57.6K Buy
6,611
+569
+9% +$5.97K ﹤0.01% 1411
2024
Q4
$75.2K Sell
6,042
-31
-0.5% -$381 ﹤0.01% 1163
2024
Q3
$70.5K Buy
6,073
+1,982
+48% +$22.9K ﹤0.01% 1072
2024
Q2
$43.5K Sell
4,091
-95
-2% -$1.05K ﹤0.01% 1112
2024
Q1
$50K Sell
4,186
-104
-2% -$1.25K ﹤0.01% 1065
2023
Q4
$46.5K Buy
4,290
+1,194
+39% +$11.4K ﹤0.01% 1088
2023
Q3
$30.5K Sell
3,096
-20
-0.6% -$208 ﹤0.01% 1227
2023
Q2
$31.1K Buy
3,116
+347
+13% +$3.31K ﹤0.01% 1234
2023
Q1
$26.6K Sell
2,769
-543
-16% -$6.02K ﹤0.01% 1255
2022
Q4
$36.9K Buy
3,312
+29
+0.9% +$303 ﹤0.01% 1155
2022
Q3
$27K Sell
3,283
-12,242
-79% -$120K ﹤0.01% 1237
2022
Q2
$166K Sell
15,525
-138
-0.9% -$1.51K 0.01% 818
2022
Q1
$170K Buy
15,663
+1,513
+11% +$19.9K 0.01% 865
2021
Q4
$191K Buy
14,150
+3,593
+34% +$48K 0.01% 889
2021
Q3
$143K Buy
10,557
+738
+8% +$10.5K 0.01% 1011
2021
Q2
$144K Sell
9,819
-1,317
-12% -$19.1K 0.01% 1001
2021
Q1
$148K Buy
11,136
+633
+6% +$10.3K ﹤0.01% 1108
2020
Q4
$146K Buy
+10,503
New +$171K 0.01% 966

Other funds holding VTRS

Geneos Wealth Management's VTRS Position: Q2 2026 in Review

Geneos Wealth Management increased its Viatris (VTRS) stake by 0.35% in Q2 2026, buying an estimated $201 and bringing the position to 3,677 shares worth $58.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1401.

Geneos Wealth Management first reported a position in VTRS in Q4 2020 and has held it in 23 quarters since. The position peaked at $191K in Q4 2021. 1,033 funds tracked by Wall St. Rank hold VTRS as of Q2 2026.

  • Geneos Wealth Management held 3,677 shares of Viatris worth $58.4K as of Q2 2026.
  • Geneos Wealth Management bought 13 Viatris shares in Q2 2026, an estimated $201.
  • Viatris made up ﹤0.01% of Geneos Wealth Management's portfolio in Q2 2026, its #1401 holding.
  • Geneos Wealth Management first reported a position in Viatris in Q4 2020 and has held it in 23 quarters since.
  • Geneos Wealth Management's Viatris position peaked at $191K in Q4 2021.
  • 1,033 funds tracked by Wall St. Rank held Viatris as of Q2 2026.

Based on Geneos Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.